APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer

Abstract Background Recent studies have demonstrated that APOC1 is associated with cancer progression, exerting cancer-promoting and immune infiltration-promoting effects. Nevertheless, there is currently no report on the presence of APOC1 in ovarian cancer (OV). Method In this study, we conducted d...

Full description

Bibliographic Details
Main Authors: Shimin Yang, Jingxiao Du, Wei Wang, Dongmei Zhou, Xiaowei Xi
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-12105-z
_version_ 1827310164954316800
author Shimin Yang
Jingxiao Du
Wei Wang
Dongmei Zhou
Xiaowei Xi
author_facet Shimin Yang
Jingxiao Du
Wei Wang
Dongmei Zhou
Xiaowei Xi
author_sort Shimin Yang
collection DOAJ
description Abstract Background Recent studies have demonstrated that APOC1 is associated with cancer progression, exerting cancer-promoting and immune infiltration-promoting effects. Nevertheless, there is currently no report on the presence of APOC1 in ovarian cancer (OV). Method In this study, we conducted data analysis using the GEO and TCGA databases. We conducted a thorough bioinformatics analysis to investigate the function of APOC1 in OV, utilizing various platforms including cBioPortal, STRING, GeneMANIA, LinkedOmics, GSCALite, TIMER, and CellMarker. Additionally, we performed immunohistochemical staining on tissue microarrays and conducted in vitro cellular assays to validate our findings. Result Our findings reveal that APOC1 expression is significantly upregulated in OV compared to normal tissues. Importantly, patients with high APOC1 levels show a significantly poorer prognosis. Furthermore, our study demonstrated that APOC1 exerted a crucial function in promoting the capacity of ovarian cancer cells to proliferate, migrate, and invade. Additionally, we have identified that genes co-expressed with APOC1 are primarily associated with adaptive immune responses. Notably, the levels of APOC1 in OV exhibit a correlation with the presence of M2 Tumor-associated Macrophages (TAMs). Conclusion APOC1 emerges as a promising prognostic biomarker for OV and exhibits a significant association with M2 TAMs in OV.
first_indexed 2024-04-24T19:55:17Z
format Article
id doaj.art-b339b5035d7547d09b22cb3fe7b155f1
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-24T19:55:17Z
publishDate 2024-03-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-b339b5035d7547d09b22cb3fe7b155f12024-03-24T12:23:25ZengBMCBMC Cancer1471-24072024-03-0124111610.1186/s12885-024-12105-zAPOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancerShimin Yang0Jingxiao Du1Wei Wang2Dongmei Zhou3Xiaowei Xi4Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDivision of Gynecologic Oncology, Department of Gynecology and Obstetrics, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background Recent studies have demonstrated that APOC1 is associated with cancer progression, exerting cancer-promoting and immune infiltration-promoting effects. Nevertheless, there is currently no report on the presence of APOC1 in ovarian cancer (OV). Method In this study, we conducted data analysis using the GEO and TCGA databases. We conducted a thorough bioinformatics analysis to investigate the function of APOC1 in OV, utilizing various platforms including cBioPortal, STRING, GeneMANIA, LinkedOmics, GSCALite, TIMER, and CellMarker. Additionally, we performed immunohistochemical staining on tissue microarrays and conducted in vitro cellular assays to validate our findings. Result Our findings reveal that APOC1 expression is significantly upregulated in OV compared to normal tissues. Importantly, patients with high APOC1 levels show a significantly poorer prognosis. Furthermore, our study demonstrated that APOC1 exerted a crucial function in promoting the capacity of ovarian cancer cells to proliferate, migrate, and invade. Additionally, we have identified that genes co-expressed with APOC1 are primarily associated with adaptive immune responses. Notably, the levels of APOC1 in OV exhibit a correlation with the presence of M2 Tumor-associated Macrophages (TAMs). Conclusion APOC1 emerges as a promising prognostic biomarker for OV and exhibits a significant association with M2 TAMs in OV.https://doi.org/10.1186/s12885-024-12105-zAPOC1Ovarian cancerImmune responseM2 TAMsBiomarker
spellingShingle Shimin Yang
Jingxiao Du
Wei Wang
Dongmei Zhou
Xiaowei Xi
APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
BMC Cancer
APOC1
Ovarian cancer
Immune response
M2 TAMs
Biomarker
title APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
title_full APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
title_fullStr APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
title_full_unstemmed APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
title_short APOC1 is a prognostic biomarker associated with M2 macrophages in ovarian cancer
title_sort apoc1 is a prognostic biomarker associated with m2 macrophages in ovarian cancer
topic APOC1
Ovarian cancer
Immune response
M2 TAMs
Biomarker
url https://doi.org/10.1186/s12885-024-12105-z
work_keys_str_mv AT shiminyang apoc1isaprognosticbiomarkerassociatedwithm2macrophagesinovariancancer
AT jingxiaodu apoc1isaprognosticbiomarkerassociatedwithm2macrophagesinovariancancer
AT weiwang apoc1isaprognosticbiomarkerassociatedwithm2macrophagesinovariancancer
AT dongmeizhou apoc1isaprognosticbiomarkerassociatedwithm2macrophagesinovariancancer
AT xiaoweixi apoc1isaprognosticbiomarkerassociatedwithm2macrophagesinovariancancer